...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >NOVEL METHODS FOR THE VISIBLE SPECTROPHOTOMETRIC DETERMINATION OF PIPAZETHATE HCl AND CHLORPHENOXAMINE HCl IN PURE AND TABLET DOSAGE FORMS
【24h】

NOVEL METHODS FOR THE VISIBLE SPECTROPHOTOMETRIC DETERMINATION OF PIPAZETHATE HCl AND CHLORPHENOXAMINE HCl IN PURE AND TABLET DOSAGE FORMS

机译:可见分光光度法测定纯净和片剂用量中的哌嗪盐酸盐和氯苯氧明盐酸盐

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Three rapid, simple, precise and sensitive visible spectrophotometric methods (A-C) have been developed for the determination of pipazethate hydrochloride (PZ-HCl) and Chlorphenoxamine hydrochloride (CPA-HCl) in pure and Tablet Dosage Forms. Both methods (A-C) involves the formation of intense yellow ion-association complex between drug(s) and either of picric acid (PA) or phenol red (PR) or chlorophenol red (CPR) reagents followed by extraction with methylene chloride. The ion-associates exhibit absorption maxima at 359, 393 and 405 nm for PZ-HCl and at 357, 388 and 400 nm for CPA-HCl with PA, PR and CPR, respectively. The calibration curves resulting from the measurements of absorbance¨Cconcentration relations (at the optimum reaction conditions) of the extracted ion-association complexes are linear over the concentration range 3.05-43.60, 8.72-104.64 and 3.27-49.05 |ìg/mL for PZ-HCl and 3.40-47.64, 8.51-88.48 and 3.40-40.84 |ìg/mL for CPA-HCl with PA, PR and CPR, respectively. The molar absorptivities and Sandell's sensitivities of the reaction products were calculated. In methods (A-C) the slope, intercept, correlation coefficient, relative standard deviation (RSD), detection and quantitation limits were also calculated. No interference was observed from common excipients present in pharmaceutical formulations. The results are well compared to those obtained by the reference methods using Students t- and F-tests. Therefore, the present methods are suitable for the drugs determination, as they are accurate and precise to a high extent
机译:已经开发了三种快速,简单,精确和灵敏的可见分光光度法(A-C),用于测定纯净剂量和片剂剂量形式的盐酸哌哌齐酯(PZ-HCl)和盐酸氯苯甲胺盐酸盐(CPA-HCl)。两种方法(A-C)都涉及一种或多种药物与苦味酸(PA)或酚红(PR)或氯酚红(CPR)试剂之间形成强烈的黄色离子缔合复合物,然后用二氯甲烷萃取。离子缔合体对于PZ-HCl分别在359、393和405 nm处显示最大吸收,对于带有PA,PR和CPR的CPA-HCl分别在357、388和400 nm处显示最大吸收。提取的离子缔合配合物的吸光度-浓度关系(在最佳反应条件下)的测量结果得出的校准曲线在PZ-的浓度范围3.05-43.60、8.72-104.64和3.27-49.05 |ìg/ mL内呈线性。对于分别含PA,PR和CPR的CPA-HCl,HCl和3.40-47.64、8.51-88.48和3.40-40.84 |μg/ mL。计算了反应产物的摩尔吸光度和Sandell敏感性。在方法(A-C)中,还计算了斜率,截距,相关系数,相对标准偏差(RSD),检测和定量限。没有观察到存在于药物制剂中的常见赋形剂的干扰。与通过学生t检验和F检验通过参考方法获得的结果进行了很好的比较。因此,本方法适合于药物测定,因为它们在很大程度上是准确和精确的

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号